Top Story

Spark Therapeutics reports $2.3 million in revenue in first quarter

May 25, 2015

Spark Therapeutics, developer of SPK-RPE65, a potential gene therapy treatment for RPE65-mediated inherited retinal degenerations, reported $2.3 million in revenue in the first quarter of 2015 compared with $20,000 in the same quarter of 2014. The company recognized $1.3 million of revenue associated with a collaboration with Pfizer, according to a press release.

Net loss was reported at $10.4 million, or $0.58 per common share, in the first quarter compared with $4.4 million, or $0.86 per common share, in the same quarter in 2014.

Business News

Early safety data favorable for pSivida’s Medidur for posterior uveitis

May 22, 2015
Early IOP safety data are encouraging for Medidur, a treatment for posterior uveitis in phase 3 trial, pSivida announced in a press release.At 3 months, only 4% more…
Breaking News

Ampio reports positive results in DME patients treated with Optina

May 22, 2015
Ampio Pharmaceuticals reported positive results in the phase 3 OptimEyes trial in patients with diabetic macular edema, according to a press release. The multiple site…

Nutritional designed to help athletes see better

May 21, 2015
ZeaVision announced the launch of EyePromise Vizual Edge Chewable, a once-daily tablet intended to help athletes see better so they can react faster and maximize their…
Meeting News Coverage Video
VIDEO: Shire moves into rare disease treatment in ophthalmology

VIDEO: Shire moves into rare disease treatment in ophthalmology

May 6, 2015
DENVER — At the Association for Research in Vision and Ophthalmology meeting here, Robert Dempsey, vice president and…
More »
Business News

Spark Therapeutics reports $2.3 million in revenue in first quarter

May 25, 2015
Spark Therapeutics, developer of SPK-RPE65, a potential gene therapy treatment for RPE65-mediated inherited retinal degenerations, reported $2.3…
Business News

Early safety data favorable for pSivida’s Medidur for posterior uveitis

May 22, 2015
Early IOP safety data are encouraging for Medidur, a treatment for posterior uveitis in phase 3 trial, pSivida announced in a press release.At 3…
Breaking News

Ampio reports positive results in DME patients treated with Optina

May 22, 2015
Ampio Pharmaceuticals reported positive results in the phase 3 OptimEyes trial in patients with diabetic macular edema, according to a press release…

Nutritional designed to help athletes see better

May 21, 2015
ZeaVision announced the launch of EyePromise Vizual Edge Chewable, a once-daily tablet intended to help athletes see better so they can react faster…
Meeting News Coverage

Remarkable achievements toward trachoma eradication in Algeria honored with Golden Medal of Trachoma

May 21, 2015
PARIS — Amar Ailem, MD, a professor at Algiers University, Algeria, was awarded this year's Golden Medal of Trachoma by the International…
Business News

Allegro receives US patent for integrin peptide therapy Luminate

May 20, 2015
Allegro announced a U.S. patent was issued for Luminate for “composition of matter” and “methods of use in the treatment of various…
Business News

Alimera reports 86% increase in revenue in first quarter

May 19, 2015
Alimera Sciences reported net revenue of $3.9 million in the first quarter of 2015, an 86% increase from the first quarter of 2014. The increase was…
Breaking News

EBI-005 fails to meet co-primary endpoints in phase 3 study for dry eye disease

May 18, 2015
EBI-005 failed to meet its co-primary endpoints in a pivotal phase 3 study in patients with moderate to severe dry eye disease, according to top-line…

Circuit court grants injunction of Utah UPP ban

May 18, 2015
The 10th Circuit Court of Appeals entered a temporary injunction on a Utah law that would prohibit the use of unilateral pricing policies for…

Healio.com wins Sitecore Experience Award

May 18, 2015
THOROFARE, N.J. — Healio.com, the online portal of The Wyanoke Group and SLACK Incorporated, has been named winner of the 2014 North American…
More Headlines »
morganatic-roan